Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Sr. VP, Gen. Counsel & Secy. | January 27, 2004 | January 28, 2004 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date January 27, 2004 · Filed January 28, 2004
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 76,705 |
Last balance in matching sequence
After 2004-01-27 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2004-01-27 · Exercise / conversion · Acquired 7,572 · Balance 84,277 F1: (SMO 1/27/2004) The amount of the securities beneficially held by the reporting person (i) has been adjusted to reflect an acquisition of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)(B) and (ii) does not include 4,852 shares held indirectly by the Charitable Remainder Trust (the "Trust"). The reporting person, who is the co-trustee pursuant to the terms of the Trust, is entitled to an annual percentage of the net fair market value of the assets of the Trust and hereby disclaims beneficial ownership, except to the extent of such interest. Row 2 · 2004-01-27 · Sale · Disposed 7,572 · Balance 76,705 F1: (SMO 1/27/2004) The amount of the securities beneficially held by the reporting person (i) has been adjusted to reflect an acquisition of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)(B) and (ii) does not include 4,852 shares held indirectly by the Charitable Remainder Trust (the "Trust"). The reporting person, who is the co-trustee pursuant to the terms of the Trust, is entitled to an annual percentage of the net fair market value of the assets of the Trust and hereby disclaims beneficial ownership, except to the extent of such interest. |
| NQSO (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.14 · Expires 2004-07-01 | Direct | 0 |
Reported balance
After 2004-01-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2004-01-27 · Exercise / conversion · Disposed 7,572 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: (SMO 1/27/2004) The amount of the securities beneficially held by the reporting person (i) has been adjusted to reflect an acquisition of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)(B) and (ii) does not include 4,852 shares held indirectly by the Charitable Remainder Trust (the "Trust"). The reporting person, who is the co-trustee pursuant to the terms of the Trust, is entitled to an annual percentage of the net fair market value of the assets of the Trust and hereby disclaims beneficial ownership, except to the extent of such interest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 27, 2004 Filed Jan 28, 2004 23:02 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 7,572 | $0.00 Strike: $14.14 | $0.00 |
DisclosureSEC source: 0001181431-04-005010 · rrd30544.xml · derivative · entry 3 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,572 shares Expires 2004-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2004 Filed Jan 28, 2004 23:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 7,572 | $65.00 | $492,180.00 |
DisclosureSEC source: 0001181431-04-005010 · rrd30544.xml · nonDerivative · entry 2 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,705 F1 · balance_after: (SMO 1/27/2004) The amount of the securities beneficially held by the reporting person (i) has been adjusted to reflect an acquisition of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)(B) and (ii) does not include 4,852 shares held indirectly by the Charitable Remainder Trust (the "Trust"). The reporting person, who is the co-trustee pursuant to the terms of the Trust, is entitled to an annual percentage of the net fair market value of the assets of the Trust and hereby disclaims beneficial ownership, except to the extent of such interest. Read SEC document |
| January 27, 2004 Filed Jan 28, 2004 23:02 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 7,572 | $14.14 | $107,073.38 |
DisclosureSEC source: 0001181431-04-005010 · rrd30544.xml · nonDerivative · entry 1 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (SMO 1/27/2004) The amount of the securities beneficially held by the reporting person (i) has been adjusted to reflect an acquisition of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)(B) and (ii) does not include 4,852 shares held indirectly by the Charitable Remainder Trust (the "Trust"). The reporting person, who is the co-trustee pursuant to the terms of the Trust, is entitled to an annual percentage of the net fair market value of the assets of the Trust and hereby disclaims beneficial ownership, except to the extent of such interest. Read SEC document |
| November 21, 2003 Filed Nov 21, 2003 23:19 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $14.14 | $0.00 |
DisclosureSEC source: 0001181431-03-032431 · rrd23631.xml · derivative · entry 3 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,572 Underlying: Common Stock · 15,000 shares Expires 2004-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2003 Filed Nov 21, 2003 23:19 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 15,000 | $60.26 | $903,825.00 |
DisclosureSEC source: 0001181431-03-032431 · rrd23631.xml · nonDerivative · entry 2 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,199 F1 · balance_after: (SMO 11/21/03) Does not include 4,852 shares indirectly held by the Odre Charitable Remainder Trust (the "Trust"). The reporting person, who is the co-trustee pursuant to the terms of the Trust, is entitled to an annual percentage of the net fair market value of the assets of the Trust and hereby disclaims beneficial ownership, except to the extent of such interest. Read SEC document |
| November 21, 2003 Filed Nov 21, 2003 23:19 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 15,000 | $14.14 | $212,110.50 |
DisclosureSEC source: 0001181431-03-032431 · rrd23631.xml · nonDerivative · entry 1 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (SMO 11/21/03) Does not include 4,852 shares indirectly held by the Odre Charitable Remainder Trust (the "Trust"). The reporting person, who is the co-trustee pursuant to the terms of the Trust, is entitled to an annual percentage of the net fair market value of the assets of the Trust and hereby disclaims beneficial ownership, except to the extent of such interest. Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:27 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 98,482 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012814 · rrd11627.xml · derivative · entry 2 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Cousel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,482 Underlying: Common Stock · 98,482 shares Expires 2010-07-01 F2 · price: 0 F1 · derivative.exercise_date: (SMO-07/03-NQSO) The option becomes exercisable for 20,000 shares on July 1, 2004; 20,000 shares on July 1, 2005; 20,000 shares on July 1, 2006; 20,000 shares on July 1, 2007; and 18,482 shares on July 1, 2008 respectively. Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:27 UTC | AMGEN INC AMGN · Entity 2832 | GrantISO (Right to Buy) · Derivative | 1,518 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012814 · rrd11627.xml · derivative · entry 1 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Cousel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,518 Underlying: Common Stock · 1,518 shares Expires 2010-07-01 F2 · price: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.